Published in
American Society for Pharmacology and Experimental Therapeutics, Journal of Pharmacology and Experimental Therapeutics, 2(365), p. 301-313
Links
Tools
Preclinical Efficacy and Safety of the Novel Antidiabetic, Antiobesity MetAP2 Inhibitor ZGN-1061
Journal article published in 2018 by
Bryan F. Burkey,
Niel C. Hoglen,
Philip Inskeep,
Margaret Wyman,
Thomas E. Hughes,
James E. Vath
Distributing this paper is prohibited by the publisher
Full text: Unavailable
Preprint: archiving forbidden
Postprint:
archiving forbidden
Data provided by 
